Radiotherapy Versus Low-Dose Tamoxifen Following Breast Conserving Surgery for Low-Risk Breast Ductal Carcinoma in Situ

Condition:   Breast Ductal Carcinoma in Situ Interventions:   Drug: Low-dose tamoxifen;   Radiation: Whole breast radiotherapy Sponsors:   National Taiwan University Hospital;   Tri-Service General Hospital;   Koo Foundation Sun Yat-Sen Cancer Center;   Kaohsiung Medical University;   Kyoto University;   Mackay Memorial Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials